Last 7 days
-0.6%
Last 30 days
-4.1%
Last 90 days
-8.8%
Trailing 12 Months
9.8%
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 5.3% | 1,429,135,000 | 1,356,660,000 | 1,267,569,000 | 1,176,194,000 | 1,066,414,000 |
Operating Expenses | 3.9% | 1,429,996,000 | 1,375,782,000 | 1,308,287,000 | 1,225,147,000 | 1,303,304,000 |
S&GA Expenses | 3.2% | 20,366,000 | 19,741,000 | 18,368,000 | 17,868,000 | 24,227,000 |
EBITDA | 60.8% | -14,804,000 | -37,759,000 | -47,835,000 | -235,775,000 | - |
EBITDA Margin | 63.4% | -0.01 | -0.03 | -0.04 | -0.22 | - |
Earnings Before Taxes | 109.3% | 1,726,000 | -18,580,000 | -41,513,000 | -50,325,000 | -237,901,000 |
EBT Margin | 58.2% | -0.01 | -0.03 | -0.04 | -0.22 | - |
Interest Expenses | 168.2% | 542,000 | -795,000 | -1,372,000 | -1,011,000 | - |
Net Income | 278.7% | 15,343,000 | -8,585,000 | -39,823,000 | -50,562,000 | -212,666,000 |
Net Income Margin | 79.9% | -0.01 | -0.03 | -0.04 | -0.20 | - |
Free Cahsflow | 759.0% | 47,092,000 | 5,482,000 | 51,807,000 | 51,633,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 10.4% | 875 | 793 | 808 | 745 | 723 |
Current Assets | 6.7% | 589 | 552 | 580 | 521 | 493 |
Cash Equivalents | -10.6% | 311 | 348 | 317 | 292 | 316 |
Net PPE | -8.6% | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 |
Goodwill | 6.4% | 135 | 127 | 127 | 127 | 128 |
Liabilities | 16.5% | 319 | 274 | 317 | 278 | 265 |
Current Liabilities | 17.2% | 310 | 264 | 305 | 265 | 220 |
Shareholder's Equity | 11.5% | 557 | 499 | 470 | 467 | 458 |
Retained Earnings | 3.4% | -209 | -216 | -234 | -236 | -225 |
Additional Paid-In Capital | 1.0% | 721 | 715 | 704 | 680 | 660 |
Accumulated Depreciation | 7.9% | 4.00 | 4.00 | 4.00 | - | - |
Shares Outstanding | 0.7% | 115 | 115 | 114 | 110 | 108 |
Minority Interest | 116.7% | 43.00 | 20.00 | 21.00 | 22.00 | 23.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | -17.1% | 39.00 | 47.00 | 6.00 | 52.00 | 52.00 |
Share Based Compensation | -28.9% | 48.00 | 67.00 | 83.00 | 94.00 | 278 |
Cashflow From Investing | -23867.3% | -24.93 | -0.10 | -32.47 | -32.65 | -32.81 |
Cashflow From Financing | 3.9% | -18.90 | -19.68 | -18.47 | -27.14 | 215 |
86.2%
86.2%
67.9%
Y-axis is the maximum loss one would have experienced if Privia Health Group was unfortunately bought at previous high price.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-23 | Brookfield Corp /ON/ | reduced | -64.42 | -1,628,750 | 1,241,680 | -% |
2023-05-23 | ROYCE & ASSOCIATES LP | added | 25.97 | 929,500 | 2,678,170 | 0.03% |
2023-05-22 | AMERIPRISE FINANCIAL INC | sold off | -100 | -1,414,000 | - | -% |
2023-05-18 | JPMORGAN CHASE & CO | added | 13.61 | 1,144,000 | 4,143,000 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -21.23 | -29,000 | 674,000 | -% |
2023-05-16 | COLONY GROUP LLC | reduced | -1.8 | 311,000 | 1,917,000 | 0.03% |
2023-05-16 | JANE STREET GROUP, LLC | new | - | 358,433 | 358,433 | -% |
2023-05-16 | CASTLEARK MANAGEMENT LLC | sold off | -100 | -3,330,310 | - | -% |
2023-05-16 | SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | reduced | -39.41 | -520,447 | 1,455,320 | 0.03% |
2023-05-16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -65.18 | -1,369,640 | 1,005,670 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
May 15, 2023 | durable capital partners lp | 7.9% | 9,090,909 | SC 13G | |
May 12, 2023 | pamplona capital partners iii, l.p. | 0% | 0 | SC 13G/A | |
Feb 14, 2023 | pamplona capital partners iii, l.p. | 15.5% | 17,741,723 | SC 13G/A | |
Feb 14, 2023 | goldman sachs group inc | 21.7% | 24,824,660 | SC 13G/A | |
Feb 14, 2023 | sullivan william m | 5.1% | 5,860,117 | SC 13G | |
Apr 29, 2022 | pamplona capital partners iii, l.p. | 18.8% | 20,019,808 | SC 13G/A | |
Apr 05, 2022 | sullivan william m | 5.9% | 6,356,713 | SC 13G | |
Feb 14, 2022 | goldman sachs group inc | 26.4% | 28,007,452 | SC 13G | |
Feb 14, 2022 | pamplona capital partners iii, l.p. | 18.8% | 20,019,808 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
May 16, 2023 | 4 | Insider Trading | |
May 15, 2023 | 4 | Insider Trading | |
May 15, 2023 | SC 13G | Major Ownership Report | |
May 12, 2023 | SC 13G/A | Major Ownership Report | |
May 11, 2023 | 144 | Notice of Insider Sale Intent | |
May 11, 2023 | 4 | Insider Trading | |
May 11, 2023 | 4 | Insider Trading | |
May 11, 2023 | 4 | Insider Trading | |
May 11, 2023 | 4 | Insider Trading | |
May 10, 2023 | 8-K | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-12 | Sullivan William M | sold | -481,781 | 26.54 | -18,153 | - |
2023-05-11 | Mehrotra Parth | acquired | 450 | 2.00 | 225 | president and coo |
2023-05-11 | Mehrotra Parth | sold | -6,300 | 28.00 | -225 | president and coo |
2023-05-09 | Sullivan William M | sold | -39,091 | 30.07 | -1,300 | - |
2023-05-09 | Bartrum Thomas | acquired | 136 | 2.00 | 68.00 | evp, general counsel |
2023-05-09 | Bartrum Thomas | sold | -2,040 | 30.00 | -68.00 | evp, general counsel |
2023-05-09 | Mehrotra Parth | acquired | - | - | 73,529 | president and coo |
2023-05-09 | Mountcastle David | acquired | - | - | 22,058 | evp & chief financial officer |
2023-05-09 | Bartrum Thomas | acquired | - | - | 18,382 | evp, general counsel |
2023-05-08 | GOLDMAN SACHS GROUP INC | sold | -536,473,000 | 21.615 | -24,819,500 | - |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue | $ 386,276 | $ 313,801 |
Operating expenses: | ||
Provider expense | 302,255 | 242,187 |
Cost of platform | 44,730 | 41,272 |
Sales and marketing | 5,286 | 4,661 |
General and administrative | 25,951 | 36,110 |
Depreciation and amortization | 1,340 | 1,118 |
Total operating expenses | 379,562 | 325,348 |
Operating income (loss) | 6,714 | (11,547) |
Interest (income) expense, net | (1,813) | 232 |
Income (loss) before provision for income taxes | 8,527 | (11,779) |
Provision for income taxes | 2,125 | 6,308 |
Net income (loss) | 6,402 | (18,087) |
Less: loss attributable to non-controlling interests | (922) | (577) |
Net income (loss) attributable to Privia Health Group, Inc. | $ 7,324 | $ (17,510) |
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders – basic (in dollars per share) | $ 0.06 | $ (0.16) |
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders – diluted (in dollars per share) | $ 0.06 | $ (0.16) |
Weighted average common shares outstanding - basic (in shares) | 115,009,010 | 108,059,064 |
Weighted average common shares outstanding – diluted (in shares) | 124,328,964 | 108,059,064 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 311,229 | $ 347,992 |
Accounts receivable | 260,881 | 189,604 |
Prepaid expenses and other current assets | 16,667 | 14,366 |
Total current assets | 588,777 | 551,962 |
Non-current assets: | ||
Property and equipment, net | 3,095 | 3,386 |
Right-of-use asset | 7,618 | 8,089 |
Intangible assets, net | 97,637 | 57,387 |
Goodwill | 135,050 | 126,938 |
Deferred tax asset | 38,503 | 40,368 |
Other non-current assets | 4,663 | 4,683 |
Total non-current assets | 286,566 | 240,851 |
Total assets | 875,343 | 792,813 |
Current liabilities: | ||
Accounts payable and accrued expenses | 46,300 | 52,837 |
Provider liability | 260,368 | 208,424 |
Operating lease liabilities, current | 3,021 | 3,013 |
Total current liabilities | 309,689 | 264,274 |
Non-current liabilities: | ||
Operating lease liabilities, non-current | 7,788 | 8,490 |
Other non-current liabilities | 1,345 | 1,000 |
Total non-current liabilities | 9,133 | 9,490 |
Total liabilities | 318,822 | 273,764 |
Commitments and contingencies (Note 11) | ||
Stockholders’ equity: | ||
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 115,469,961 and 114,690,808 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 1,159 | 1,148 |
Additional paid-in capital | 721,486 | 714,639 |
Accumulated deficit | (209,369) | (216,693) |
Total Privia Health Group, Inc. stockholders’ equity | 513,276 | 499,094 |
Non-controlling interest | 43,245 | 19,955 |
Total stockholders’ equity | 556,521 | 519,049 |
Total liabilities and stockholders’ equity | $ 875,343 | $ 792,813 |